{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:36:45Z","timestamp":1793939805796,"version":"4.8.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2010,4,9]],"date-time":"2010-04-09T00:00:00Z","timestamp":1270771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Oral immunotherapy with inactivated non-typeable Haemophilus influenzae (NTHi) prevents exacerbations of chronic obstructive pulmonary disease, but the mechanism is unclear. The aim of this study was to determine the mechanism of protection. This was a placebo versus active prospective study over 3 months in 64 smokers. The active treatment was three courses of oral NTHi given at monthly intervals, followed by measurement of bacteriological and immunological parameters. The results can be summarized: (i) NTHi-specific T cells increased in the placebo treatment group over time (P\u2003&amp;lt;\u20030\u00b705); (ii) the T cell response in the oral NTHi group started earlier than that in the placebo group (P\u2003&amp;lt;\u20030\u00b705); and (iii) serum NTHi-specific immunoglobulin (Ig)G had significantly greater variation in the placebo group (P\u2003&amp;lt;\u20030\u00b70001). The increase in antibody in placebos over time correlated with exposure to live H. influenzae (P\u2003&amp;lt;\u20030\u00b705) determined from culture of gargles; (iv) reduction in saliva lysozyme over time (P\u2003&amp;lt;\u20030\u00b705) was detected only in the oral NTHi treatment group. These data are consistent with T cell priming of gut lymphoid tissue by aspiration of bronchus content into the gut, with oral immunotherapy augmenting this process leading to enhanced bronchus protection. The evidence for protection was a stable IgG antibody level through the study in the oral NTHi treatment group, contrasting with an increase in antibody correlating with exposure of the airways to H. influenzae in the placebo group. Saliva lysozyme was a useful biomarker of mucosal inflammation, falling after oral NTHi consistent with a reduction in the level of intralumenal inflammation.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04142.x","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T02:13:41Z","timestamp":1273025621000},"page":"127-133","source":"Crossref","is-referenced-by-count":13,"title":["Oral non-typable <i>Haemophilus influenzae<\/i> enhances physiological mechanism of airways protection"],"prefix":"10.1093","volume":"161","author":[{"given":"R L","family":"Clancy","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Health, University of Newcastle"},{"name":"Hunter Immunology Ltd, David Maddison Building, University of Newcastle"},{"name":"Immunology, Hunter Area Pathology Service, HNEHS, John Hunter Hospital, Newcastle, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Dunkley","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Health, University of Newcastle"},{"name":"Hunter Immunology Ltd, David Maddison Building, University of Newcastle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,4,9]]},"reference":[{"key":"2021122708484461000_b1","volume-title":"Global Initiative for COPD: Global Strategy for the Diagnosis, Management and Prevention of COPD","year":"2006"},{"key":"2021122708484461000_b2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"2021122708484461000_b3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.2005.041822","article-title":"COPD exacerbations \u2013 2: aetiology","volume":"61","author":"Sapey","year":"2006","journal-title":"Thorax"},{"key":"2021122708484461000_b4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1378\/chest.129.2.223","article-title":"Coinfection in exacerbations of COPD: a new frontier","volume":"129","author":"Sethi","year":"2006","journal-title":"Chest"},{"key":"2021122708484461000_b5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1378\/chest.117.5_suppl_1.286S","article-title":"Bacteria infection and the pathogenesis of COPD","volume":"117","author":"Sethi","year":"2000","journal-title":"Chest"},{"key":"2021122708484461000_b6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1445-5994.1990.tb00367.x","article-title":"Bacterial colonisation of the respiratory tract in chronic bronchitis","volume":"20","author":"Butt","year":"1990","journal-title":"Aust NZ J Med"},{"key":"2021122708484461000_b7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/icb.1995.64","article-title":"Acute on chronic bronchitis: a model of mucosal immunology","volume":"73","author":"Clancy","year":"1995","journal-title":"Immunol Cell Biol"},{"key":"2021122708484461000_b8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.mcp.0000208451.50231.8f","article-title":"Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease","volume":"12","author":"Eldika","year":"2006","journal-title":"Curr Opin Pulmon Med"},{"key":"2021122708484461000_b9","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1164\/ajrccm.164.11.2104093","article-title":"Non-typeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis","volume":"164","author":"Bandi","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2021122708484461000_b10","first-page":"68","article-title":"A role for intestinal T lymphocytes on bronchus mucosal immunity","volume":"74","author":"Wallace","year":"1991","journal-title":"Immunology"},{"key":"2021122708484461000_b11","first-page":"362","article-title":"A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung","volume":"83","author":"Dunkley","year":"1994","journal-title":"Immunology"},{"key":"2021122708484461000_b12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-5699(95)80165-0","article-title":"An important role for intestinally derived T cells in respiratory defence","volume":"16","author":"Dunkley","year":"1995","journal-title":"Immunol Today"},{"key":"2021122708484461000_b13","first-page":"499","article-title":"Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis","volume":"63","author":"Cassatella","year":"1988","journal-title":"Immunology"},{"key":"2021122708484461000_b14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/iai.61.2.671-679.1993","article-title":"Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene \u03b24","volume":"61","author":"Buret","year":"1993","journal-title":"Infect Immun"},{"key":"2021122708484461000_b15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/icb.1995.64","article-title":"Acute on chronic bronchitis: a model of mucosal immunology","volume":"73","author":"Clancy","year":"1995","journal-title":"Immunol Cell Biol"},{"key":"2021122708484461000_b16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(85)92559-0","article-title":"Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease","volume":"2","author":"Clancy","year":"1985","journal-title":"Lancet"},{"key":"2021122708484461000_b17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/ajrccm\/144.2.324","article-title":"Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea","volume":"144","author":"Lehmann","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2021122708484461000_b18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5694\/j.1326-5377.1990.tb125268.x","article-title":"Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae","volume":"152","author":"Clancy","year":"1990","journal-title":"Med J Aust"},{"key":"2021122708484461000_b19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1445-5994.1991.tb01346.x","article-title":"A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis","volume":"21","author":"Tandon","year":"1991","journal-title":"Aust NZ J Med"},{"issue":"1","key":"2021122708484461000_b20","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1093\/infdis\/165-Supplement_1-S194","article-title":"Specific protection against acute bronchitis associated with nontypeable Haemophilus influenzae","volume":"165","author":"Clancy","year":"1992","journal-title":"J Infect Dis"},{"key":"2021122708484461000_b21","volume-title":"Oral immunotherapy with inactivated non-typeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD","author":"Tandon"},{"key":"2021122708484461000_b22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0192-0561(87)90052-X","article-title":"Efficacy of oral immunization against non-typeable Haemophilus influenzae in man","volume":"9","author":"Yeung","year":"1987","journal-title":"Int J Immunopharmacol"},{"key":"2021122708484461000_b23","first-page":"261","article-title":"Control of bacterial colonisation of the respiratory tract mucosa in man","volume-title":"Mucosal solutions","author":"Clancy","year":"1997"},{"key":"2021122708484461000_b24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1084\/jem.134.1.224","article-title":"The distribution of 51Cr-labelled lymphocytes into antigen-stimulated mice","volume":"134","author":"Zatz","year":"1971","journal-title":"J Exp Med"},{"key":"2021122708484461000_b25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mi.2009.100","article-title":"Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa","volume":"5","author":"Khader","year":"2009","journal-title":"Mucosal Immunol"},{"key":"2021122708484461000_b26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1513\/pats.200508-089JS","article-title":"Humoral immune defense (antibodies)","volume":"2","author":"Twigg","year":"2005","journal-title":"Proc Am Thor Soc"},{"key":"2021122708484461000_b27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1164\/ajrccm\/140.2.311","article-title":"An animal model demonstration of enhanced clearance of nontypable Haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue","volume":"140","author":"Wallace","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2021122708484461000_b28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2249.1995.tb03798.x","article-title":"A possible role for lysozyme in determining acute exacerbation in chronic bronchitis","volume":"102","author":"Taylor","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2021122708484461000_b29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1164\/rccm.200810-1540OC","article-title":"C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease","volume":"179","author":"Van Durme","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2021122708484461000_b30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pupt.2005.05.001","article-title":"Markers of disease severity in chronic obstructive pulmonary disease","volume":"19","author":"Franciosi","year":"2006","journal-title":"Pulmon Pharmacol Ther"},{"key":"2021122708484461000_b31","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm1583","article-title":"Anti-elastin autoimmunity in tobacco smoking-induced emphysema","volume":"18","author":"Lee","year":"2007","journal-title":"Nat Med"},{"key":"2021122708484461000_b32","first-page":"1","article-title":"Lung myeloid dendritic cells coordinately induce Th1 and Th17 responses in human emphysema","volume":"1.4","author":"Shan","year":"2009","journal-title":"Sci Transl Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04142.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/161\/1\/127\/41925509\/j.1365-2249.2010.04142.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/161\/1\/127\/41925509\/j.1365-2249.2010.04142.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:23:14Z","timestamp":1641054194000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/161\/1\/127\/6429001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,4,9]]},"published-print":{"date-parts":[[2010,6,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04142.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,7]]},"published":{"date-parts":[[2010,4,9]]}}}